Sun Pharma Advanced Research Company (SPARC) has suffered a net loss of Rs 17.90 crore in the quarter ended December 31, 2011. The company had reported a net loss of Rs 2.94 crore for the third quarter last fiscal.
Total income of the company stood at Rs 4.51 crore in the quarter ended December 31, 2011. It was Rs 12.17 crore in the corresponding period last fiscal, down by 62.94%.
SPARC was demerged from Sun Pharma as a pharma research and drug discovery company in 2007.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: